Methyl group deficiency and guanidino production in uremia

Molecular and Cellular Biochemistry

Volumn 244, Issue 1-2, 2003, Pages 31-36

  Cohen, Burton D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Argininosuccinic acid; Betaine; Guanidinosuccinic acid; Methionine; Methyl groups; Uremic toxins

Indexed keywords

ARGININOSUCCINIC ACID; CHOLINE; FREE RADICAL; GUANIDINOSUCCINIC ACID; HOMOCYSTEINE; METHIONINE; METHYL GROUP; UREMIC TOXIN;

AMINO ACID DEFICIENCY; AMINO ACID SUBSTITUTION; ANOREXIA; BLOOD VESSEL INJURY; DIET RESTRICTION; ENZYME INHIBITION; HUMAN; KIDNEY FAILURE; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PROTEIN RESTRICTION; REVIEW; TOXICITY TESTING; UREMIA;

ANIMALS; ARGININE; FREE RADICALS; GUANIDINES; HOMOCYSTEINE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LIVER; METHIONINE; MITOCHONDRIA; MODELS, BIOLOGICAL; MODELS, CHEMICAL; OXYGEN; SUCCINATES; TIME FACTORS; TRANSAMINASES; UREMIA;

ANIMALIA;

EID: 0037306157     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022483117996     Document Type: Review

References (42)

1. Bonas JE, Cohen BD, Natelson S: Separation and estimation of certain guanidino compounds. Application to human urine. Microchem J 7: 63-77, 1963
2. Cohen BD, Stein IM, Bonas JE: Guanidinosuccinic aciduria in uremia. Am J Med 45: 63-68, 1968
3. Aoyagi K, Ohba S, Narita M, Tojo S: Regulation of the biosynthesis of guanidinosuccinic acid in isolated rat hepatocytes and in vivo. Kidney Int 24: S224-S228, 1983
4. Kopple JD, Gordon SI, Wang M, Swendseid ME: Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects. J Lab Clin Med 90: 303-311, 1977
5. Stein IM, Cohen BD, Kornhauser RS: Guanidinosuccinic acid in renal failure, experimental azotemia and inborn errors of the urea cycle. N Engl J Med 280: 926-930, 1969
6. Perez G, Abraira C, Rey A, Horn M: Removal of guanidinosuccinic acid by hemodialysis. Nephron 19: 214-219, 1977
7. Cohen BD: Guanidinosuccinic acid in uremia. Arch Intern Med 126: 846-850, 1970
8. Dobelstein H, Edel HH, Schmidt M, Schubart G, Wenzierl M: Guanidinosuccinic acid and uremia: A clinical study. Klin Wochenschr 49: 348-357, 1971
9. Horowitz HI, Cohen BD, Martinez P, Papayyoanou MF: Defective ADP-induced platelet factor 3 activation in uremia. Blood 30: 331-340, 1967
10. Horowitz HI, Stein IM, Cohen BD, White JG: Further studies on the platelet inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am J Med 49: 336-345, 1970
11. Lonergan ET, Semar M, Sterzel RB, Tresor G, Needle MA, Voyles L, Lange K: Erythrocyte transketolase activity in dialyzed patients: A reversible metabolic lesion of uremia. N Engl J Med 284: 1399-1403, 1971
12. Slavin RD, Fitch CD: Inhibition of lymphocyte transformation by guanidinosuccinic acid, a surplus metabolite. Experientia 27: 1340-1341, 1971
13. Shainkin-Kestenbaum R, Winikoff Y, Dvilansky A, Chaimowitz C, Nathan I: Effect of guanidinopropionic acid on lymphocyte proliferation. Nephron 44: 295-298, 1987
14. Acquatella H, Perez-Rojas M, Burger B, Lozano JR: Experimental modification of myocardial contractility produced by a toxin retained in uremia: Guanidinosuccinic acid. Arch Inst Cardiol Mex 44: 624-639, 1974
15. Acquatella H, Perez-Rojas M, Burger B, Quinan-Baldo A: Left ventricular function in terminal uremia: A hemodynamic and echocardiographic study. Nephron 22: 160-174, 1978
16. Scheuer J, Stezoski SW: The effect of uremic compounds on cardiac function and metabolism. J Mol Cell Cardiol 5: 287-300, 1973
17. Cohen BD, Handelsman DG, Pai BN: Toxicity arising from the urea cycle. Kidney Int 7: S285-S287, 1975
18. Patel H, Cohen BD: The effect of inhibitors of cytochrome P-450 microsomal enzymes on the biosynthesis of potential uremic toxins. Ann NY Acad Sci 434: 468-470, 1984
19. Aoyagi K, Nagase S, Tomida C, Takemura K, Akiyama K, Koyama A: Synthesis of guanidinosuccinate from argininosuccinate and reactive oxygen in vitro. Enzyme Prot 49: 199-204, 1996
20. Aoyagi K, Nagase S, Gotoh M, Akiyama K, Safoh M, Hirayama A, Koyama A: Role of reactive oxygen and argininosuccinate in guanidinosuccinate synthesis in isolated rat hepatocytes. Enzyme Prot 49: 205-211, 1996
21. Aoyagi K, Shahrzad S, Iida S, Tomida C, Hirayama A, Nagase S, Cohen BD: Role of nitric oxide in the synthesis of guanidinosuccinic acid, an activator of the N-methyl-D-aspartate receptor. Kidney Int 59: S93-S96, 2001
22. Menyhart Y, Grof J, Somogyi J: Abstracts of the 9th Annu Meet Eur Soc Clin Invest 9: 37-38, 1975
23. Aoyagi K: Significance of reactive oxygen in kidney disease elucidated by uremic toxins: From uremia to nephrosis. In: T. Yoshikawa, S. Toyokuni, Y. Yamamoto, Y. Naito (eds). Free Radicals in Chemistry, Biology and Medicine, ch. 42. OICA International, London, 2000, pp 1-7
24. Bohles H, Cohen BD, Michalk D: Guanidinosuccinic acid excretion in argininosuccinic aciduria. Adv Exp Med Biol 153: 443-448, 1982
25. Cohen BD: Guanidinosuccinic acid in uremia. Arch Int Med 162: 846-950, 1970
26. Aoyagi K, Teraoka S: The artificial kidney for the treatment of redox state abnormalities in renal failure. J Artif Organs 4: 1-2, 2001
27. Palmer RMJ: The L-arginine nitric oxide pathway. Curr Opin Nephrol Hypertens 2: 122-128, 1993
28. Cohen BD, Patel H: Glycine in acute renal tubular necrosis. In: P.P. DeDeyn, B. Marescau, I.A. Qureshi, A. Mori (eds). Guanidino Compounds in Biology and Medicine 2. John Libbey, London, 1997, pp 273-277
29. Aoyagi K, Akiyama K, Shahrzad S, Tomida C, Hirayama A, Nagase S, Takemura K, Koyama A, Ohba S, Narita M: Formation of guanidinosuccinic acid, a stable nitric oxide mimic, from argininosuccinic acid and nitric oxide-derived free radicals. Free Radic Res 31: 59-65, 1999
30. Aoyagi K: Inhibition of arginine synthesis by urea: a new mechanism of arginine deficiency in renal failure which leads to increased hydroxyl radical generation. Mol Cell Biochem 39: (abstr), 2, 2001
31. Mudd SH, Levy, HI: Disorders of transulfuration. In: J. Stanbury (ed). The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, 1978, 460 pp
32. Cohen BD, Patel H, Kornhauser RS: Alternate reasons for atherogenesis in uremia. Proc Dialysis Transplant Forum 7: 178-180, 1977
33. Cohen BD: Guanidino compounds: Implications in uremia. In: A. Mori, B.D. Cohen, A. Lowenthal (eds). Guanidines. Plenum Press, New York, 1985, pp 265-275
34. Cohen BD: Homocysteine and the guanidines: An alternate source of atherogenesis in uremia. In: J.F. Clark, A. Mori, I. Masashi (eds). Guanidino Compounds in Biology and Medicine. Blackwell Science, Japan, 1999, pp 259-262
35. McCully KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111-123, 1969
36. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosisin prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974
37. Cohen BD, Patel H: Methionine and the control of creatine synthesis. Ann NY Acad Sci 494: 329-331, 1987
38. Mudd SH: Homocystinuria and homocysteine metabolism. In: W.L. Nyhan (ed). Heritable Disorders of Amino Acid Metabolism. Wiley, New York, 1974, 372 pp
39. Mudd SH: Methyl group transfer. In: W.H. Fishman (ed). Metabolic Conjugation and Metabolic Hydrolysis. Lippincott, Philadelphia, 1971, pp 297-343
40. Avram MM, Sreedhara R, Fein P, Oo KK, Chattopadhyay J, Mittman N: Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters. Am J Kidney Dis 37: S77-S80, 2001
41. Van Guldener C, Janssen MJFM, DeMeer K, Donker AJM, Stehouwer CDA: Effect of folic acid and betaine on fasting and post methionine-loading plasma homocysteine and methionine levels in chronic hemodialysis patients. J Int Med 245: 175-183, 1999
42. Manns B, Hyndman E, Burgess E, Parsons H, Schaefer J, Snyder F, Scott-Douglas N: Oral vitamin B12 and high dose folic acid in hemodialysis patients with hyper-homocysteinemia. Kidney Int 59: 1103-1109, 2001